- Tips for starting an SGLT2 inhibitor
- 10 Opportunities to increase access to physicians through IT efficiencies
- Should patients w/ diabetes, CKD and proteinuria despite RAASi & SGLT2i be considered for add-on therapy with finerenone (triple therapy)?
- Most impactful clinical trials: slowing progression of chronic kidney disease
- 7 ways the EMPA-KIDNEY trial will impact clinical care in CKD
- Personalized decision support and the move from NNT to iNNT
- Will SPRINT Change Our Systolic BP Target in Hypertensive Patients from 140 to 120 mm Hg?
- Preventative Foot Care Project May Reduce Amputations, Hospitalization and Length of Stay in ESRD
- Temporary Visitor Visas for Donating a Kidney